University of Ulsan College of Medicine Reports Findings in Type 2 Diabetes [Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, ...]

Media coverage

• Title	University of Ulsan College of Medicine Reports Findings in Type 2 Diabetes [Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, ...]
  Media name/outlet	South Korea Daily Report
  Country/Territory	United States
  Date	23/10/24
  Persons	Beom-Joon Lee